Cargando…

CPT: Pharmacometrics & Systems Pharmacology – Inception, Maturation, and Future Vision

Detalles Bibliográficos
Autores principales:	Rowland Yeo, Karen, Hennig, Stefanie, Krishnaswami, Sriram, Strydom, Natasha, Ayyar, Vivaswath S., French, Jonathan, Sinha, Vikram, Sobie, Eric, Zhao, Ping, Friberg, Lena E., Mentré, France
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302238/ https://www.ncbi.nlm.nih.gov/pubmed/34298582 http://dx.doi.org/10.1002/psp4.12680

Ejemplares similares

CPT: Pharmacometrics & Systems Pharmacology 2.0
por: Mentré, France
Publicado: (2019)

Welcome to the statistics and pharmacometrics themed issue
por: French, Jonathan, et al.
Publicado: (2021)

CPT: Pharmacometrics and Systems Pharmacology
por: van der Graaf, Piet H
Publicado: (2012)

CPT: Pharmacometrics & Systems Pharmacology
Publicado: (2013)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

CPT: Pharmacometrics & Systems Pharmacology Publishes Its 100th Article
por: van der Graaf, P H, et al.
Publicado: (2014)

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)
por: Sinha, Vikram, et al.
Publicado: (2021)

Database: A New Article Type in CPT: Pharmacometrics & Systems Pharmacology
por: Li, L, et al.
Publicado: (2015)

Tutorials on the Foundations of Pharmacometrics and Systems Pharmacology
por: Friberg, L E
Publicado: (2013)

Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions
por: Ayyar, Vivaswath S., et al.
Publicado: (2021)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

ATLAS mPBPK: A MATLAB‐Based Tool for Modeling and Simulation of Minimal Physiologically‐Based Pharmacokinetic Models
por: Mavroudis, Panteleimon D., et al.
Publicado: (2019)

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
por: Nguyen, THT, et al.
Publicado: (2017)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel
por: Krishnan, Sreenath M., et al.
Publicado: (2021)

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012)

Pharmacometrics and Systems Pharmacology Software Tutorials and Use: Comments and Guidelines for PSP Contributions
por: Vicini, P, et al.
Publicado: (2013)

Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase‐positive non‐small cell lung cancer
por: Gupta, Neeraj, et al.
Publicado: (2022)

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

Variable or variate? A conundrum in pharmacometrics exposure–response models
por: Grisic, Ana‐Marija, et al.
Publicado: (2022)

A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients
por: Schindler, E, et al.
Publicado: (2017)

A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response Theory
por: Schindler, Emilie, et al.
Publicado: (2018)

Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

Barriers to global pharmacometrics: educational challenges and opportunities across the globe
por: Michelet, Robin, et al.
Publicado: (2023)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Pharmacometric Characterization of Dabigatran Hemodialysis
por: Liesenfeld, Karl-Heinz, et al.
Publicado: (2013)

CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
por: Välitalo, Pyry Antti Juhana
Publicado: (2021)

Quantitative tissue-specific dynamics of in vivo GILZ mRNA expression and regulation by endogenous and exogenous glucocorticoids
por: Ayyar, Vivaswath S, et al.
Publicado: (2015)

Application of ggplot2 to Pharmacometric Graphics
por: Ito, K, et al.
Publicado: (2013)

Confidence and Prediction Intervals for Pharmacometric Models
por: Kümmel, Anne, et al.
Publicado: (2018)

Precision Medicine in Pharmacometrics and Systems Pharmacology
por: Li, L
Publicado: (2017)

Time to Expect More From Pharmacometrics
por: Barrett, Jeffrey S.
Publicado: (2020)

Generation and application of avatars in pharmacometric modelling
por: Chasseloup, Estelle, et al.
Publicado: (2023)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
por: Hennig, Stefanie, et al.
Publicado: (2019)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members
por: Mentré, F, et al.
Publicado: (2013)

Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis
por: Ayyar, Vivaswath S., et al.
Publicado: (2022)

Visualization and Communication of Pharmacometric Models With Berkeley Madonna
por: Krause, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2rdl1sule667fddfcni92i7qkp